Cargando…
The Application of CRISPR/Cas9 for the Treatment of Retinal Diseases
The CRISPR/Cas9 system of genome editing has revolutionized molecular biology, offering a simple, and relatively inexpensive method of creating precise DNA edits. It has potential application in gene therapy treatment of retinal diseases providing targeted disruption, alteration, or transcriptional...
Autores principales: | Peddle, Caroline F., MacLaren, Robert E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
YJBM
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733850/ https://www.ncbi.nlm.nih.gov/pubmed/29259519 |
Ejemplares similares
-
CRISPR Interference–Potential Application in Retinal Disease
por: Peddle, Caroline F., et al.
Publicado: (2020) -
CRISPR-Cas9 DNA Base-Editing and Prime-Editing
por: Kantor, Ariel, et al.
Publicado: (2020) -
RNA Editing as a Therapeutic Approach for Retinal Gene Therapy Requiring Long Coding Sequences
por: Fry, Lewis E., et al.
Publicado: (2020) -
An analysis of the Kozak consensus in retinal genes and its relevance to gene therapy
por: McClements, Michelle E., et al.
Publicado: (2021) -
Non-Viral Delivery of CRISPR/Cas Cargo to the Retina Using Nanoparticles: Current Possibilities, Challenges, and Limitations
por: Salman, Ahmed, et al.
Publicado: (2022)